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Heat shock proteins (HSPs) are evolutionary 
highly conserved proteins that play a pivotal 
function in intracellular protein folding and 
quality control, and thus are essential for 
maintaining cellular protein homeostasis. It 
is well-known however that in higher eukar-
yotes the roles of HSPs are not limited to 
protein folding. HSPs can activate both the 
innate and adaptive immune system, with 
the latter function attributed to their ability 
to shuttle antigens into both the MHC class 
I and class II antigen processing pathways. 
These diverse functions of HSPs have led 
to their development as vaccine vehicles for 
tumor immunotherapy. At the same time, 
the mechanisms underlying the diverse 
effects of HSPs are poorly understood. 
Murshid et al. (2012) provide an excellent 
overview of current knowledge on the path-
ways contributing to cross-presentation of 
HSP-associated antigens by MHC class I 
molecules, and on potential mechanisms 
supporting the induction of robust CD8 
T cell responses to HSP-delivered antigens. 
The authors identify different scavenger 
receptors that are expressed on dendritic 
cells (DC) and have been shown to bind 
extracellular HSPs, leading to antigen 
cross-presentation. They summarize the 
possible molecular pathways contributing 
to cross-presentation of scavenger recep-
tor internalized, HSP-delivered antigens 
by MHC class I molecules, which include 
the vacuolar or endosome–plasma membrane 
pathway for short HSP-associated epitopes, 
as tested for Hsp90, and the endosome to 
cytosol – cell membrane pathway for larger 
HSP-associated polypeptides (Ackerman 
et al., 2003; Cresswell et al., 2005; Rock and 
Shen, 2005). Interestingly, in accord with 
the pleiotropic roles of HSPs, especially in 
the latter antigen processing pathway that 
is dependent on proteasomes and TAP, the 
role of HSPs may well extend beyond their 
use as vehicles to target antigens to the 
DC, with roles in endosomal escape, and 
targeting of the antigens to proteasomes 
being implied. Such a function of HSPs 
would well fit with numerous other stud-
ies, showing a role of endogenous Hsp90 in 
MHC class I antigen processing, probably 
by protecting proteasome-released peptides 
from premature degradation, allowing TAP-
mediated transport into the ER where they 
may bind to MHC class I heavy chain/
β2-microglobulin complexes (Srivastava 
et al., 1994; Kunisawa and Shastri, 2006). 
Nevertheless, while it is clear that HSP-
delivered antigens can be cross-presented, 
the triggers leading to immune activation 
are less well defined. The authors discuss 
potential mechanisms by which HSPs can 
create a local inflammatory environment, 
supporting the induction of robust CD8 T 
cell responses to HSP-delivered antigens. 
In the first place, the MHC class I anti-
gen cross-presentation and MHC class II 
antigen presentation pathway intersect in 
the endosomal compartments. Thus, HSP-
delivered antigens will be processed both 
for presentation by MHC class I and class 
II molecules, the last allowing the activa-
tion of CD4 T cells which, at least under 
sterile conditions, are required for DC 
licensing. In addition, HSPs may function 
as DAMPs (damage-associated molecular 
patterns) and engage in interactions with 
pattern recognition receptors such as TLR2 
to stimulate the innate immune system and 
probably also to further activate the cross-
presentation pathway in DC (Amigorena 
and Savina, 2010). Moreover, HSP-bound 
scavenger receptor may concentrate in lipid 
rafts and activate cell signaling pathways, 
leading for example to NFκB activation.
On the other hand, however, binding 
of HSPs to another DC-expressed scaven-
ger receptor, SRA/CD204 inhibits immune 
 activation. In addition, HSPs have been shown 
to be released from cells in exosomes, which 
may play a role in CD8 T cell cross prim-
ing if derived from DC, but have appeared 
to be immunosuppressive if derived from 
for example EL4 thymoma cells. Besides the 
capacity to shuttle antigens into MHC class 
I and II antigen processing pathways, HSPs 
have a role as antigens seen by the adaptive 
immune response. The latter feature of HSPs 
seems to include the induction of self-HSP 
cross-reactive T and B cell responses triggered 
by the relatively immuno-dominant micro-
bial HSPs such as those of the HSP60 and 
HSP70 chaperone families. The inflamma-
tion dampening effects of microbial HSPs that 
were seen in models of experimental autoim-
munity were found to relate to induction of 
regulatory T cells capable of targeting the up-
regulated self-HSPs in inflamed tissues. The 
outcome of clinical trials testing HSP peptides 
in patients with diabetes and arthritis has lent 
further support to the immune dampening 
effects of HSPs (van Eden et al., 2005, 2012; 
Aldridge, 2012).
Taken together, while it is clear that HSPs 
deliver antigens to DC for presentation by 
both the MHC class I and class II molecules, 
the effects on the activation status of the 
immune system may as well be negative as 
positive, with the exact outcome probably 
depending on a delicate balance of signals 
received through different receptors on the 
DC and immune imprints of previous adap-
tive immune responses. This said, it also 
becomes easier to appreciate the fact that 
HSPs are used in cancer therapy, to activate 
tumor-specific CD8 T cell responses, but 
also are being developed for immunother-
apy strategies aimed to dampen immune 
responses, for treatment of autoimmune 
disease. As concluded by the authors, more 
research especially into the signaling events 
associated with the immunogenic but also 
non-immunogenic effects of HSPs will be 
needed. This to develop these further as 
highly effective and multi-functional vac-
cine vehicles.
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